260 related articles for article (PubMed ID: 24060754)
1. Lumican affects tumor cell functions, tumor-ECM interactions, angiogenesis and inflammatory response.
Nikitovic D; Papoutsidakis A; Karamanos NK; Tzanakakis GN
Matrix Biol; 2014 Apr; 35():206-14. PubMed ID: 24060754
[TBL] [Abstract][Full Text] [Related]
2. The role of SLRP-proteoglycans in osteosarcoma pathogenesis.
Nikitovic D; Berdiaki K; Chalkiadaki G; Karamanos N; Tzanakakis G
Connect Tissue Res; 2008; 49(3):235-8. PubMed ID: 18661350
[TBL] [Abstract][Full Text] [Related]
3. Lumican effects in the control of tumour progression and their links with metalloproteinases and integrins.
Brézillon S; Pietraszek K; Maquart FX; Wegrowski Y
FEBS J; 2013 May; 280(10):2369-81. PubMed ID: 23438179
[TBL] [Abstract][Full Text] [Related]
4. Lumican, a small leucine-rich proteoglycan substituted with keratan sulfate chains is expressed and secreted by human melanoma cells and not normal melanocytes.
Sifaki M; Assouti M; Nikitovic D; Krasagakis K; Karamanos NK; Tzanakakis GN
IUBMB Life; 2006 Oct; 58(10):606-10. PubMed ID: 17050378
[TBL] [Abstract][Full Text] [Related]
5. Lumican core protein inhibits melanoma cell migration via alterations of focal adhesion complexes.
Brézillon S; Radwanska A; Zeltz C; Malkowski A; Ploton D; Bobichon H; Perreau C; Malicka-Blaszkiewicz M; Maquart FX; Wegrowski Y
Cancer Lett; 2009 Sep; 283(1):92-100. PubMed ID: 19394140
[TBL] [Abstract][Full Text] [Related]
6. Focus on molecules: lumican.
Kao WW; Funderburgh JL; Xia Y; Liu CY; Conrad GW
Exp Eye Res; 2006 Jan; 82(1):3-4. PubMed ID: 16213485
[No Abstract] [Full Text] [Related]
7. Expression of lumican, a small leucine-rich proteoglycan with antitumour activity, in human malignant melanoma.
Brézillon S; Venteo L; Ramont L; D'Onofrio MF; Perreau C; Pluot M; Maquart FX; Wegrowski Y
Clin Exp Dermatol; 2007 Jul; 32(4):405-16. PubMed ID: 17490399
[TBL] [Abstract][Full Text] [Related]
8. The regulatory roles of small leucine-rich proteoglycans in extracellular matrix assembly.
Chen S; Birk DE
FEBS J; 2013 May; 280(10):2120-37. PubMed ID: 23331954
[TBL] [Abstract][Full Text] [Related]
9. Lumican is increased in experimental and clinical heart failure, and its production by cardiac fibroblasts is induced by mechanical and proinflammatory stimuli.
Engebretsen KV; Lunde IG; Strand ME; Waehre A; Sjaastad I; Marstein HS; Skrbic B; Dahl CP; Askevold ET; Christensen G; Bjørnstad JL; Tønnessen T
FEBS J; 2013 May; 280(10):2382-98. PubMed ID: 23480731
[TBL] [Abstract][Full Text] [Related]
10. Transcriptome analysis of endothelial cell gene expression induced by growth on matrigel matrices: identification and characterization of MAGP-2 and lumican as novel regulators of angiogenesis.
Albig AR; Roy TG; Becenti DJ; Schiemann WP
Angiogenesis; 2007; 10(3):197-216. PubMed ID: 17632767
[TBL] [Abstract][Full Text] [Related]
11. Lumican, pro-tumorigenic or anti-tumorigenic: A conundrum.
Appunni S; Rubens M; Ramamoorthy V; Anand V; Khandelwal M; Saxena A; McGranaghan P; Odia Y; Kotecha R; Sharma A
Clin Chim Acta; 2021 Mar; 514():1-7. PubMed ID: 33333043
[TBL] [Abstract][Full Text] [Related]
12. Microenvironmental Modulation of Decorin and Lumican in Temozolomide-Resistant Glioblastoma and Neuroblastoma Cancer Stem-Like Cells.
Farace C; Oliver JA; Melguizo C; Alvarez P; Bandiera P; Rama AR; Malaguarnera G; Ortiz R; Madeddu R; Prados J
PLoS One; 2015; 10(7):e0134111. PubMed ID: 26230845
[TBL] [Abstract][Full Text] [Related]
13. Lumican, a small leucine-rich proteoglycan.
Nikitovic D; Katonis P; Tsatsakis A; Karamanos NK; Tzanakakis GN
IUBMB Life; 2008 Dec; 60(12):818-23. PubMed ID: 18949819
[TBL] [Abstract][Full Text] [Related]
14. Lumican inhibits collagen deposition in tissue engineered cartilage.
Kafienah W; Cheung FL; Sims T; Martin I; Miot S; Von Ruhland C; Roughley PJ; Hollander AP
Matrix Biol; 2008 Jul; 27(6):526-34. PubMed ID: 18534835
[TBL] [Abstract][Full Text] [Related]
15. Proteoglycans and diseases of soft tissues.
Halper J
Adv Exp Med Biol; 2014; 802():49-58. PubMed ID: 24443020
[TBL] [Abstract][Full Text] [Related]
16. Small leucine-rich proteoglycans in kidney disease.
Schaefer L
J Am Soc Nephrol; 2011 Jul; 22(7):1200-7. PubMed ID: 21719787
[TBL] [Abstract][Full Text] [Related]
17. Proteoglycans: structure, function, and role in neoplasia.
Iozzo RV
Lab Invest; 1985 Oct; 53(4):373-96. PubMed ID: 2413275
[No Abstract] [Full Text] [Related]
18. Role of Cys41 in the N-terminal domain of lumican in ex vivo collagen fibrillogenesis by cultured corneal stromal cells.
Carlson EC; Mamiya K; Liu CY; Gendron RL; Birk DE; Funderburgh JL; Kao WW
Biochem J; 2003 Feb; 369(Pt 3):461-8. PubMed ID: 12381269
[TBL] [Abstract][Full Text] [Related]
19. Lumican regulates osteosarcoma cell adhesion by modulating TGFβ2 activity.
Nikitovic D; Chalkiadaki G; Berdiaki A; Aggelidakis J; Katonis P; Karamanos NK; Tzanakakis GN
Int J Biochem Cell Biol; 2011 Jun; 43(6):928-35. PubMed ID: 21421073
[TBL] [Abstract][Full Text] [Related]
20. Macrophage receptors for lumican. A corneal keratan sulfate proteoglycan.
Funderburgh JL; Mitschler RR; Funderburgh ML; Roth MR; Chapes SK; Conrad GW
Invest Ophthalmol Vis Sci; 1997 May; 38(6):1159-67. PubMed ID: 9152235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
